Forecast of Global Human Rabies Immunoglobulin (IM) Consumption Market 2023

Global Human Rabies Immunoglobulin (IM) market will register a 7.3% CAGR in terms of revenue, reach US$ 440 million by 2023, from US$ 290 million in 2017. Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.